MySmarTrend
← Insider Monitor
Alpha Cognition Inc. logo
ACOG

Alpha Cognition Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Alpha Cognition Inc. develops and commercializes therapies for neurological and neurodegenerative diseases, including treatments for Alzheimer's disease.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Grapevine, TX
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Opaleye Management Inc.10% OwnerBuy$157KSep 24, 2026
Opaleye Management Inc.10% OwnerBuy$114KSep 25, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ACOG.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ACOG activity by email

Free alerts for the insider and congressional trades worth watching.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.